Get started
Author

Yi Mu

COVID-19 trajectories among 57 million adults in England: a cohort study using electronic health records
2022 · Johan H Thygesen, Christopher Tomlinson, et al. · The Lancet Digital Health · 77
PDF
Healthcare utilisation of 282,080 individuals with long COVID over two years: a multiple matched control, longitudinal cohort analysis
2024 · Yi Mu, Ashkan Dashtban, et al. · Journal of the Royal Society of Medicine · 27
What is current care for people with Long COVID in England? A qualitative interview study
2024 · David Sunkersing, Mel Ramasawmy, et al. · BMJ Open · 24
Long COVID symptoms and demographic associations: A retrospective case series study using healthcare application data
2024 · David Sunkersing, Henry Goodfellow, et al. · JRSM Open · 12
STIMULATE-ICP-CAREINEQUAL (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways) study protocol: Defining usual care and examining inequalities in Long Covid support
2022 · Mel Ramasawmy, Yi Mu, et al. · PLoS ONE · 12
PDF
Vaccinations, cardiovascular drugs, hospitalization, and mortality in COVID-19 and Long COVID
2024 · Ashkan Dashtban, Mehrdad A. Mizani, et al. · International Journal of Infectious Diseases · 8
PDF
Efficacy and safety of rivaroxaban, colchicine, and famotidine–loratadine with specialist supportive clinical care for fatigue in patients with post-COVID-19 condition in the UK: a multisite, open-label, randomised controlled trial
2026 · Emma C Wall, Gordon Prescott, et al. · The Lancet Infectious Diseases · 4
Exploring the help-seeking journeys for Long Covid from a health inequalities perspective: a qualitative study in England
2024 · Donna Clutterbuck, Mel Ramasawmy, et al. · medRxiv · 3
PDF
Healthcare utilisation and cost among individuals with Long COVID in England and Wales: potential value of specialised post-COVID services
2026 · Ashkan Dashtban, Mehrdad Mizani, et al. · Journal of the Royal Society of Medicine · 1
OP13 Projected ethnic inequalities in multimorbidity prevalence in England, 2026–2040: a CPRD-based dynamic microsimulation study
2026 · Joshua Edefo, Anna Head, et al. · Journal of Epidemiology & Community Health
PDF
Integrated care pathway in individuals with Long COVID: STIMULATE-ICP, a cluster-randomized, phase 3 trial
2026 · Writing Group, Amitava Banerjee, et al. · Nature Medicine
PDF
Incidence and prevalence of Takayasu arteritis in England before and after the COVID-19 pandemic: results from RECORDER
2026 · Stephanie J Lax, Mehrdad A Mizani, et al. · Rheumatology Advances in Practice
Association of COVID-19 and influenza vaccinations and cardiovascular drugs with hospitalisation and mortality in COVID-19 and Long COVID: 2-year follow-up of 17 million individuals in England
2024 · A Dashtban, M Mizani, et al. · European Heart Journal
Works count: 14
Citation count: 168
H-index: 6
I10-index: 5
Year
Topic
Type